Project Grant R34DA060477
Award Date
9/15/24
Completion Date
7/31/27
Dollars Obligated
$242K
Federal Agency
National Institute on Drug Abuse
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Durham, NC 27705, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $1,485,691 to Duke University to evaluate the neural correlates and behavioral impact of withdrawal-induced hyperalgesia (increased pain sensitivity) among people who smoke, with and without chronic pain. The key objectives are to: 1) Examine the impact of smoking withdrawal on brain fMRI responses to noxious heat stimuli, and 2) Investigate...
This Project Grant award of $431,643, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and pilot testing of a telehealth-delivered, pain-targeted motivational smoking intervention for smokers with chronic pain who are not ready to quit. The project aims to adapt an existing in-person intervention to a telehealth format and evaluate its feasibility and acceptability in a pilot randomized controlled...
The National Institute on Drug Abuse (NIDA) awarded Duke University a Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate digital envirotyping methods for characterizing the everyday environments of people who smoke. The $763,766 award, which runs from July 2025 to March 2030, aims to (1) advance digital envirotyping and enviromarker development to identify environmental triggers of smoking relapse, and (2) increase understanding of...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $395,566 to Flik Therapeutics, Inc. to support the development of a novel FDA-regulated pharmacotherapy and multimodal nicotine cessation program. The goal is to create a more effective smoking cessation therapy compared to the current standard of care, which has low success rates. This Phase I proposal will fund the initial development of the...
This Project Grant award of $3,257,011 from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will fund a randomized controlled trial to evaluate the effectiveness of switching to electronic nicotine delivery systems (ENDS) compared to nicotine replacement therapy (NRT) for promoting smoking abstinence among individuals enrolled in substance use disorder (SUD) treatment programs in South Carolina. The study aims to: 1) assess...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs, provides $353,508 to Clemson University to conduct a 3-group randomized controlled trial examining the impact of electronic cigarette (EC) flavor and use patterns on harm reduction milestones (e.g., cigarette per day reduction, switching) among people with opioid use disorder on buprenorphine. The 5-year project aims to offer the principal...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a multi-method study on momentary distress intolerance and its relationship to cigarette smoking among adults with emotional distress. The $233,913 award to Rutgers, The State University will fund a 5-year research plan involving qualitative investigation, ecological momentary assessment, and longitudinal modeling to better understand...
This Project Grant award of $622,957 from the National Institutes of Health (NIH) Office of the Director, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research by Duke University to investigate the chemical composition and behavioral effects of novel tobacco products, including oral nicotine pouches and "non-menthol" cigarettes. The study aims to analyze the flavors, sweeteners, and nicotine forms in these products, and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $146,922 to Indiana University to evaluate the association between general chronic pain liability and clinically recognized substance use. The project aims to clarify the underlying mechanisms linking chronic pain and substance use disorders, accounting for heterogeneity across and comorbidity among chronic pain conditions, as well as...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $265,239 to the University of North Carolina at Chapel Hill to conduct research on the effects of vaping-induced oxidation on nicotine analogs, such as 6-methyl nicotine, used in e-cigarettes. The key objectives are to: 1) analyze the chemical composition and metabolism of 6-methyl nicotine and nicotinamide vaping devices before and after...